Live from the NIH registry
Studies recruiting near Cincinnati right now
Top 25 of 1,131 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Cincinnati Eye Institute — Blue Ash, Ohio (9.3 mi)
· Sponsor: Genentech, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Sensorineural Hearing Loss, Bilateral
Phase 3
Interventional 48 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Eli Lilly and Company
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
The Christ Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Oncology Hematology Care Clinical Trials LLC — Cincinnati, Ohio (1.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of Cincinnati Medical Center ( Site 0156) — Cincinnati, Ohio (1.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Phase 3
Interventional 117 participants sought
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension — Cincinnati, Ohio (1.1 mi)
· Sponsor: Bayer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Tri-State Gastroenterology Assoc — Crestview Hills, Kentucky (8.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Traumatic Brain Injury
N/A
Observational 2,000 participants sought
University of Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: Hoffmann-La Roche
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Good Samaritan Hospital - Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Acute Pancreatitis
Phase 1, Phase 2
Interventional 42 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: St. Jude Children's Research Hospital
BE WELL With Migraine: Brain Education and WELLness With Migraine
Migraine
N/A
Interventional 286 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Wake Forest University Health Sciences
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG
Phase 2
Interventional 60 participants sought
Cincinnati Children's Hospital — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Cincinnati, Ohio (1.1 mi)
· Sponsor: Sameek Roychowdhury
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
University of Cincinnati Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: ImmVira Pharma Co. Ltd
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Mercy Health — Cincinnati, Ohio (1.1 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
University of Cincinnati — Cincinnati, Ohio (1.1 mi)
· Sponsor: Celldex Therapeutics
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Local Institution - 0383 — Cincinnati, Ohio (1.1 mi)
· Sponsor: Bristol-Myers Squibb
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: The Society for Pediatric Anesthesia
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Cardiomyopathies, Heart Failure
N/A
Interventional 300 participants sought
TriHealth Hatton Research Institute — Cincinnati, Ohio (1.1 mi)
· Sponsor: Zoll Medical Corporation
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma
Phase 2
Interventional 38 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Nationwide Children's Hospital
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Cincinnati Children's Hospital Medical Center - PIN — Cincinnati, Ohio (1.1 mi)
· Sponsor: Takeda
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio (1.1 mi)
· Sponsor: Michigan State University